Lung cancer screening.
作者信息
Wood Douglas E, Eapen George A, Ettinger David S, Hou Lifang, Jackman David, Kazerooni Ella, Klippenstein Donald, Lackner Rudy P, Leard Lorriana, Leung Ann N C, Massion Pierre P, Meyers Bryan F, Munden Reginald F, Otterson Gregory A, Peairs Kimberly, Pipavath Sudhakar, Pratt-Pozo Christie, Reddy Chakravarthy, Reid Mary E, Rotter Arnold J, Schabath Matthew B, Sequist Lecia V, Tong Betty C, Travis William D, Unger Michael, Yang Stephen C
机构信息
University of Washington/Seattle Cancer Care Alliance, USA.
出版信息
J Natl Compr Canc Netw. 2012 Feb;10(2):240-65. doi: 10.6004/jnccn.2012.0022.
Abstract
摘要
相似文献
1
Lung cancer screening.
J Natl Compr Canc Netw. 2012 Feb;10(2):240-65. doi: 10.6004/jnccn.2012.0022.
2
Lung cancer screening.
Cancer Cytopathol. 2016 Aug;124(8):533-4. doi: 10.1002/cncy.21751. Epub 2016 Jul 14.
3
A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
Eur J Epidemiol. 2016 Feb;31(2):211-2. doi: 10.1007/s10654-015-0070-1. Epub 2015 Jul 22.
4
Lung cancer screening based on personal risk may save more lives.
Cancer. 2018 Apr 1;124(7):1315. doi: 10.1002/cncr.31320.
5
Lung cancer prevention and screening.
Oncology (Williston Park). 2014 May;28(5):449-50.
6
[Lung cancer screening--update 2014].
Pneumologie. 2014 Dec;68(12):781-3. doi: 10.1055/s-0034-1390899. Epub 2014 Dec 9.
7
Setting up a lung cancer screening program.
J Natl Compr Canc Netw. 2012 Feb;10(2):277-85. doi: 10.6004/jnccn.2012.0024.
8
Lung cancer screening in Australia: progress or procrastination?
Med J Aust. 2016 Jan 18;204(1):4-5. doi: 10.5694/mja15.01109.
9
[Screening for lung cancer].
Orv Hetil. 2012 Jun 10;153(23):904-7. doi: 10.1556/OH.2012.29396.
10
[Prevention and screening for lung cancers].
Rev Prat. 2020 Oct;70(8):843.
引用本文的文献
1
Optimizing Strategy for Lung Cancer Screening: From Risk Prediction to Clinical Decision Support.
JCO Clin Cancer Inform. 2025 May;9:e2400291. doi: 10.1200/CCI-24-00291. Epub 2025 May 7.
2
The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography SUVMax in deciding on a computed tomography-guided lung biopsy in solid solitary pulmonary nodules.
Rev Assoc Med Bras (1992). 2025 May 2;71(3):e20241741. doi: 10.1590/1806-9282.20241741. eCollection 2025.
3
Analysis of the morbidity characteristics and related factors of pulmonary nodules in patients with type 2 diabetes mellitus: a retrospective study.
BMC Endocr Disord. 2025 Jan 30;25(1):26. doi: 10.1186/s12902-025-01857-9.
4
National Survey of Lung Cancer Screening Eligibility in United States Veterans.
Am J Prev Med. 2025 May;68(5):886-895. doi: 10.1016/j.amepre.2025.01.015. Epub 2025 Jan 27.
5
Comparison of Lung-RADS Version 2022 and British Thoracic Society Guidelines in Classifying Solid Pulmonary Nodules Detected at Lung Cancer Screening CT.
Life (Basel). 2024 Dec 27;15(1):14. doi: 10.3390/life15010014.
6
Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records.
JCO Clin Cancer Inform. 2025 Jan;9:e2400139. doi: 10.1200/CCI.24.00139. Epub 2025 Jan 16.
7
Prevalence and progression rate of interstitial lung abnormalities detected on thoracic CT: a systematic review and meta-analysis.
Eur Radiol. 2025 Jan;35(1):276-288. doi: 10.1007/s00330-024-10952-9. Epub 2024 Jul 19.
8
Machine Learning for Early Discrimination Between Lung Cancer and Benign Nodules Using Routine Clinical and Laboratory Data.
Ann Surg Oncol. 2024 Nov;31(12):7738-7749. doi: 10.1245/s10434-024-15762-3. Epub 2024 Jul 16.
9
Lung cancer in the emergency department.
Emerg Cancer Care. 2023;2(1):3. doi: 10.1186/s44201-023-00018-9. Epub 2023 Mar 6.
10
Effect of a Personalized Tobacco Treatment Intervention on Smoking Abstinence in Individuals Eligible for Lung Cancer Screening.
J Thorac Oncol. 2024 Apr;19(4):643-649. doi: 10.1016/j.jtho.2023.11.012. Epub 2023 Nov 15.
本文引用的文献
1
Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial.
AJR Am J Roentgenol. 2011 Nov;197(5):1165-9. doi: 10.2214/AJR.11.6533.
2
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records.
Ann Intern Med. 2011 Aug 2;155(3):137-44. doi: 10.7326/0003-4819-155-3-201108020-00003.
3
Better evidence about screening for lung cancer.
N Engl J Med. 2011 Aug 4;365(5):455-7. doi: 10.1056/NEJMe1103776. Epub 2011 Jun 29.
4
Reduced lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.
5
Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners.
Radiat Res. 2011 Sep;176(3):375-87. doi: 10.1667/rr2377.1. Epub 2011 Jun 29.
6
Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
Radiology. 2011 Sep;260(3):658-63. doi: 10.1148/radiol.11110469. Epub 2011 Jun 28.
7
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
8
Modeling the mortality reduction due to computed tomography screening for lung cancer.
Cancer. 2011 Jun 15;117(12):2703-8. doi: 10.1002/cncr.25847. Epub 2011 Jan 10.
9
Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
J Thorac Oncol. 2011 Sep;6(9):1496-504. doi: 10.1097/JTO.0b013e318221f701.
10
Global cancer statistics.
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
Zotero 插件